Top 10 Companies in the (S)-1,2-Pentanediol (CAS 29117-54-2) Market (2026): Market Leaders Driving Global Chemical Innovation

In Business Insights
August 30, 2026

MARKET INSIGHTS

Global (S)-1,2-Pentanediol (CAS 29117-54-2) market size was valued at USD 38.6 million in 2025. The market is projected to grow from USD 41.2 million in 2026 to USD 74.8 million by 2034, exhibiting a CAGR of 6.9% during the forecast period.

(S)-1,2-Pentanediol is a chiral diol compound with the molecular formula C₅H₁₂O₂, recognized for its high optical purity and versatile functional properties. It serves as a key intermediate and active ingredient across cosmetics and personal care formulations, pharmaceutical synthesis, and specialty chemical applications. Its moisturizing efficacy, antimicrobial activity, and role as a humectant have positioned it as a valued ingredient particularly within the skincare and preservative booster segments of the personal care industry.

The market is gaining steady momentum driven by rising consumer demand for multifunctional cosmetic ingredients, expanding pharmaceutical research into chiral building blocks, and growing preference for mild yet effective preservative systems. Furthermore, increasing adoption in premium skincare formulations and the broader shift toward high‑purity specialty chemicals are reinforcing market expansion. Key producers operating across this space include Minasolve, Hangzhou Dayangchem Co., Ltd., and various specialty chemical manufacturers supplying to global personal care and pharmaceutical markets.

(S)-1,2-Pentanediol (CAS 29117-54-2) Market – View in Detailed Research Report

Top 10 Companies in the (S)-1,2-Pentanediol (CAS 29117-54-2) Market (2026)

1. Symrise AG

Headquarters: Leverkusen, Germany
Key Offering: High‑purity chiral (S)-1,2‑Pentanediol for cosmetics, fragrances, and pharmaceutical intermediates

Symrise leverages its extensive flavor and fragrance portfolio to supply (S)-1,2‑Pentanediol that meets stringent purity thresholds required by the cosmetics and pharmaceutical sectors. The company’s integrated production line ensures consistent optical purity and scalability for both specialty and bulk grades.

Sustainability and Growth Initiatives:

  • Investment in continuous‑flow synthesis to reduce solvent use and energy consumption
  • Partnerships with downstream cosmetic brands to co‑develop preservative‑boosting formulations
  • Commitment to achieving carbon‑neutral operations by 2035

2. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Specialty chiral intermediates for pharmaceutical and fine‑chemical markets

TCI’s robust asymmetric synthesis platform delivers (S)-1,2‑Pentanediol with exceptional enantiomeric excess, supporting complex drug development programs and high‑performance polymer additives.

Sustainability and Growth Initiatives:

  • Adoption of green solvents in catalytic processes
  • Collaboration with academic institutions on chiral catalyst development
  • Expansion of regional production facilities to meet Asian demand

3. Kao Corporation

Headquarters: Tokyo, Japan
Key Offering: Cosmetic‑grade humectants and emollients for skin‑care lines

Kao’s formulation expertise enables the integration of (S)-1,2‑Pentanediol into premium skincare products that emphasize skin barrier support and microbiome balance.

Sustainability and Growth Initiatives:

  • Development of biodegradable packaging for cosmetic formulations
  • Implementation of closed‑loop water systems in manufacturing
  • Launch of a sustainability reporting framework for ingredient sourcing

4. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical‑grade chiral diols for API synthesis

Merck’s advanced process chemistry capabilities provide (S)-1,2‑Pentanediol with high optical purity, facilitating the production of chiral APIs and fine‑chemical intermediates.

Sustainability and Growth Initiatives:

  • Integration of biocatalytic routes to minimize hazardous waste
  • Partnerships with contract manufacturers for scalable API production
  • Investment in renewable energy for core production sites

5. Lonza Group AG

Headquarters: Basel, Switzerland
Key Offering: Custom synthesis solutions for R&D and scale‑up of chiral intermediates

Lonza’s flexible manufacturing network supports the rapid development of (S)-1,2‑Pentanediol for niche pharmaceutical and specialty‑chemical projects.

Sustainability and Growth Initiatives:

  • Deployment of modular bioreactors for enzyme‑based synthesis
  • Collaboration with academic research centers on next‑generation chiral catalysts
  • Commitment to zero‑waste manufacturing by 2028

6. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Industrial‑grade chiral diols for polymer additives and solvent applications

BASF’s global supply chain ensures reliable delivery of high‑purity (S)-1,2‑Pentanediol to large‑scale manufacturing operations.

Sustainability and Growth Initiatives:

  • Adoption of low‑energy synthesis routes for bulk production
  • Integration of recycled feedstocks into core processes
  • Participation in industry coalitions to set sustainability benchmarks

7. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Specialty chemical intermediates for advanced materials and cosmetics

Evonik’s focus on high‑value applications drives the demand for (S)-1,2‑Pentanediol in precision‑grade formulations.

Sustainability and Growth Initiatives:

  • Development of bio‑based solvent alternatives
  • Implementation of carbon‑capture technologies in production units
  • Engagement in circular economy initiatives for chemical waste

8. Seqens

Headquarters: La Couronne, France
Key Offering: Fine‑chemical intermediates for agro‑chemical and pharmaceutical sectors

Seqens’ expertise in chiral synthesis supports the creation of (S)-1,2‑Pentanediol for high‑purity applications in agro‑chemicals.

Sustainability and Growth Initiatives:

  • Implementation of green chemistry principles across the production chain
  • Collaboration with partners to reduce overall environmental impact
  • Investment in renewable energy sources for manufacturing sites

9. Shandong INNOCRE New Materials Co., Ltd.

Headquarters: Shandong, China
Key Offering: Cost‑effective chiral diols for pharmaceutical and cosmetic applications

Shandong INNOCRE’s rapid scale‑up capabilities enable the supply of (S)-1,2‑Pentanediol to emerging markets in Asia.

Sustainability and Growth Initiatives:

  • Adoption of energy‑efficient catalytic processes
  • Use of locally sourced raw materials to reduce transportation emissions
  • Implementation of waste‑minimization protocols in production

10. Zhejiang Realsun Chemical Co., Ltd.

Headquarters: Zhejiang, China
Key Offering: Bulk chiral diols for fine‑chemical and industrial markets

Realsun’s production capacity supports the growing demand for (S)-1,2‑Pentanediol in specialty chemical and polymer sectors.

Sustainability and Growth Initiatives:

  • Integration of renewable energy into manufacturing operations
  • Development of low‑solvent synthesis routes
  • Participation in regional sustainability certification programs

Download FREE Sample Report

Get Full Report

Market Outlook (2026‑2034)

Over the next eight years, the (S)-1,2‑Pentanediol market will transition from a niche specialty chemical to a mainstream ingredient in cosmetics, pharmaceuticals, and fine‑chemical applications. The shift toward cleaner, high‑purity ingredients in personal care and the increasing reliance on enantiomerically pure intermediates in drug development will sustain demand. Geographic diversification, particularly in Asia‑Pacific and emerging economies, will drive volume growth, while regulatory clarity on chiral purity will shape market dynamics.

Future Trends and Emerging Opportunities

  • Adoption of enzymatic and biocatalytic synthesis routes that lower carbon footprints and reduce solvent use
  • Expansion of (S)-1,2‑Pentanediol into dermocosmetic lines that emphasize skin barrier repair and microbiome‑friendly formulations
  • Growing demand for high‑purity chiral diols in agro‑chemical and polymer additive markets driven by stricter environmental standards
  • Integration of digital traceability tools to enhance supply‑chain transparency for regulated end‑markets

Segment Analysis

Segment Category Sub‑Segments Key Insights
By Type
  • Pharmaceutical Grade
  • Cosmetic Grade
  • Industrial Grade
Pharmaceutical Grade dominates due to its superior purity and stereochemical integrity, essential for chiral synthesis in drug development.
By Application
  • Humectants
  • Solvents
  • Emollients
  • Chiral Intermediates
  • Others
Humectants leads as it excels in moisture retention properties, particularly valued in cosmetic and personal care formulations for maintaining skin hydration without irritation.
By End User
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Food & Beverage
  • Industrial Manufacturing
Personal Care & Cosmetics is the frontrunner, driven by rising consumer demand for natural‑derived, high‑performance ingredients in skincare products.
By Purity Level
  • High Purity (Chiral)
  • Standard Purity
  • Technical Grade
High Purity (Chiral) prevails owing to stringent requirements in advanced applications such as stereoselective reactions and bioactive compound synthesis.
By Distribution Channel
  • Direct Sales
  • Distributors
  • Online Platforms
Distributors command the forefront through established networks that provide reliable supply chains, technical support, and customized volumes to diverse end‑users.

Competitive Landscape

The market is dominated by a handful of specialty chemical leaders that have built expertise in chiral synthesis and high‑purity production. Symrise AG, Tokyo Chemical Industry Co., Ltd., and Kao Corporation hold a combined market share exceeding 60%, reflecting their advanced asymmetric synthesis technologies and integrated supply chains. Emerging players from China, such as Shandong INNOCRE New Materials Co., Ltd. and Zhejiang Realsun Chemical Co., Ltd., are expanding capacity to capture growth in industrial and pharmaceutical segments. The competitive environment is driven by the need for scalable, cost‑effective, and environmentally friendly production routes, prompting continuous investment in biocatalysis and continuous‑flow technologies.